All Research
    PAPER CERAMIReview2025

    Ceramide Testing for Major Adverse Cardiovascular Events

    2025 American Family Physician diagnostic review of the MI-Heart Ceramides test: a 0-12 ceramide risk score (three ceramides and three ratios, quartile-scored) that stratifies 1-5-year risk of major adverse cardiovascular events in adults; not FDA-approved.

    Evidence

    —

    Not Rated

    Sample

    —

    subjects

    Duration

    —

    study period

    Journal

    American Family Physician

    Feb 2025

    03

    Structured Methods

    Study Design
    Review
    Sample Size
    Not reported
    Study Duration
    Not reported
    Methodology
    Not reported
    Limitations
    Not reported
    04

    Citations & References

    Cite this paper

    Unknown authors (2025). Ceramide Testing for Major Adverse Cardiovascular Events. American Family Physician.

    Source

    Publisher

    Journal

    American Family Physician

    05

    Indexing

    Biomarkers

    ceramides
    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation